Rebecca Colman

Employment

• University of California San Diego Assistant Professor
  2022 - Present
• University of California San Diego Research Scientist
  2020 - 2022
• University of California San Diego Project Scientist
  2019 - 2020
• University of California San Diego Postdoctoral Scholar
  2016 - 2019
• Translational Genomics Research Institute Postdoctoral Fellow
  2013 - 2016
• Translational Genomics Research Institute Research Associate II
  2010 - 2013

Education

• Northern Arizona University PhD
  2005 - 2010
• Linfield College BS
  2001 - 2005

Projects & Funding

Projects & funding information is unavailable.

Publications (55)

• Cepheid 9-gene host mRNA expression across the spectrum of Mycobacterium tuberculosis infection and disease: insights across the lifespan
  eBioMedicine 2026 DOI: 10.1016/j.ebiom.2026.106462
  +Save
• Bedaquiline resistance in patients with Xpert MTB/RIF Ultra-tested rifampicin-resistant tuberculosis in the Western Cape, South Africa: a prospective study.
  Janré Steyn, Jennifer Williams, Fahd Naufal

  +12 more

  • Jason D. Limberis
  • Melanie Grobbelaar
  • Nabila A. Ismail
  • Yonas T Ghebrekristos
  • Christoffel Opperman
  • +7 more
  The Lancet. Microbe 2026 DOI: 10.1016/j.lanmic.2025.101293
  +Save
• Benchmarking Generative AI Tools for Interpretation of the WHO TB Mutation Catalogue.
  BMC digital health 2026 DOI: 10.1186/s44247-025-00225-w
  +Save
• Clinical evaluation of a commercial culture-free targeted next-generation sequencing test for diagnosis of drug-resistant tuberculosis
  Paolo Miotto, Rebecca E. Colman, Andrea Maurizio Cabibbe +15 more
  Microbiology Spectrum 2026 DOI: 10.1128/spectrum.03035-25
  +Save
• Cost-effectiveness of Targeted Next-Generation Sequencing for Tuberculosis Drug-resistance Testing as an Alternative to the Standard of Care in South Africa.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026 DOI: 10.1093/cid/ciaf495
  +Save
• Comparing end-user diagnostic outputs from a commercial tNGS pipeline for Mycobacterium tuberculosis drug resistance detection.
  IJTLD open 2025 DOI: 10.5588/ijtldopen.25.0245
  +Save
• Targeted next-generation sequencing for drug-resistant tuberculosis diagnosis: implementation considerations for bacterial load, regimen selection and diagnostic algorithm placement.
  Sophia B. Georghiou, Nestani Tukvadze, Camilla S Rodrigues +8 more
  BMJ global health 2025 DOI: 10.1136/bmjgh-2025-019135
  +Save
• Comparative assessment of line probe assays and targeted next-generation sequencing in drug-resistant tuberculosis diagnosis
  Giovanna Carpi, Marva Seifert, Andres De la Rossa +7 more
  eBioMedicine 2025 DOI: 10.1016/j.ebiom.2025.105875
  +Save
• Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples.
  Jennifer M. Williams, Janré Steyn, Emilyn Costa Conceição

  +13 more

  • Felicia Wells
  • Melanie Grobbelaar
  • Nabila A. Ismail
  • Yonas T Ghebrekristos
  • Christoffel Johannes Opperman
  • +8 more
  Journal of visualized experiments : JoVE 2025 DOI: 10.3791/68147
  +Save
• Rapid tuberculosis diagnosis from respiratory or blood samples by a low cost, portable lab-in-tube assay
  Science Translational Medicine 2025 DOI: 10.1126/scitranslmed.adp6411
  +Save
• Prospective Exploratory Evaluation of Cepheid Xpert Mycobacterium tuberculosis Host Response Cartridge: A Focus on Adolescents and Young Adults.
  Marva Seifert, Donald G. Catanzaro, Michael Gracia

  +9 more

  • Naomi Hillery
  • Sabira Tahseen
  • Faisal Masood
  • Alamdar Hussain
  • Uzma Majeed
  • +4 more
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2025 DOI: 10.1093/cid/ciae461
  +Save
• Evaluating culture-free targeted next-generation sequencing for diagnosing drug-resistant tuberculosis: a multicentre clinical study of two end-to-end commercial workflows.
  Rebecca E. Colman, Marva Seifert, Andres De la Rossa +12 more
  The Lancet. Infectious diseases 2024 DOI: 10.1016/s1473-3099(24)00586-3
  +Save
• Cartridge-based sequencing for bedaquiline resistance detection from sputum.
  IJTLD open 2024 DOI: 10.5588/ijtldopen.24.0124
  +Save
• Designing molecular diagnostics for current tuberculosis drug regimens
  Emerging Microbes & Infections 2023 DOI: 10.1080/22221751.2023.2178243
  +Save
• Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort
  Journal of Clinical Microbiology 2023 DOI: 10.1128/jcm.01478-22
  +Save
• In silico evaluation of WHO-endorsed molecular methods to detect drug resistant tuberculosis.
  Scientific reports 2022 DOI: 10.1038/s41598-022-21025-6
  +Save
• Contributions of GeneXpert® to TB diagnosis in Myanmar.
  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2022 DOI: 10.5588/ijtld.22.0009
  +Save
• The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: A genotypic analysis.
  Walker, T, Paolo Miotto, Claudio Umberto Köser +28 more
  The Lancet. Microbe 2022 DOI: 10.1016/s2666-5247(21)00301-3
  +Save
• Detecting rifampin and isoniazid resistance in Mycobacterium tuberculosis direct from patient sputum using an automated integrated system.
  Journal of clinical tuberculosis and other mycobacterial diseases 2022 DOI: 10.1016/j.jctube.2022.100304
  +Save
• Age and sex distribution of Mycobacterium tuberculosis infection and rifampicin resistance in Myanmar as detected by Xpert MTB/RIF.
  BMC infectious diseases 2021 DOI: 10.1186/s12879-021-06296-0
  +Save